Executive Summary
Global Assisted Reproductive Technology Market was valued at USD 24133.23 Million in the year 2019. Delay in age of first time pregnancy has led to lowering of total fertility rate (TFR) globally. Growing stress levels, escalation in pollution levels, modern lifestyle with increase in alcohol consumption and smoking are all cumulatively leading to increase in male and female infertility. Acceptance of homosexual couples and single mothers surging in number for use of ART are anticipated to lead market growth in the forecast period of 2020-2025.
Various techniques such as In Vitro fertilization (IVF), Artificial Insemination, Zygote Intra-fallopian transfer (ZIFT), Gamete Intra-fallopian Transfer (GIFT) are used according to need of the patient. In Vitro fertilization is considered as Gold standard for ART due to high success rate for embryo transfer and increase in live birth rates. Drugs such as orals and hormones which are injectable, are used prior to ART treatment and also during the treatment to prepare the body. Drugs market is estimated to grow heavily with elaborate pipeline. Moreover, INVOcell and Anecova have developed In vivo ART devices, which are likely to facilitate market growth in the forecast period.
Among the regions, Asia Pacific, followed by Europe and Americas, will experience the highest growth rate owing to decrease in male and female fertility.
Scope of the Report
- The report analyses Assisted Reproductive Technology Market at global, regional and country-levels.
- The report analyses Assisted Reproductive Technology Market By Technology (In vitro Fertilization, Artificial Insemination, Others).
- The report assesses the Assisted Reproductive Technology Market By End User (Hospitals, Fertility clinics).
- The report assesses the Assisted Reproductive Technology Market By Products (Consumables, Instruments, Software and Services, Drugs).
- The Global Assisted Reproductive Technology Market has been analysed By Region (Americas, Europe, Asia Pacific) and By Country (USA, Canada, Brazil, Mexico, China, Japan, India, UK, Germany, Italy).
- The key insights of the report have been presented through the frameworks of Key developments and drug pipeline phases. Also, the attractiveness of the market has been presented by Technology, End User, Products and Region. Additionally, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
- The companies analysed in the report include Merck, Hamilton Thorne, Cooper Surgical, Nidacon International AB, Anecova, Esco, INVO Bioscience, Monash IVF Group, Irvine Scientific.
- The report presents the analysis of Assisted Reproductive Technology market for the historical period of 2015-2019 and the forecast period of 2020-2025.
Key Target Audience
- Pharmaceutical Firms
- IVF Clinics and Hospitals
- Consulting and Advisory Firms
- Medical Practitioners
Global Assisted Reproductive Technology (ART) Market - Analysis By Technology (IVF, Artificial Insemination, Others), Products, End User, By Region, By Country (2020 Edition): Market Insight, Competition and Forecast (2020-2025)
Table of Contents
1. Research Methodology and Executive Summary
1.1 Research Methodology
1.2 Executive Summary
2. Strategic Recommendations
2.1 Focus on Development of Low Cost Technology
2.2 Focus on Emerging Markets
3. Assisted Reproductive Technology Market: Product Outlook
4. Global Assisted Reproductive Technology Market: Sizing and Forecast
4.1 Market Size, By Value, Year 2015-2025
5. Global ART Market Segmentation - By Technology
5.1 Competitive Scenario of Global ART: By Technology
5.2 IVF - Market Size and Forecast (2015-2025)
5.3 AI - Market Size and Forecast (2015-2025)
5.4 Others - Market Size and Forecast (2015-2025)
6. Global ART Market Segmentation - By End User
6.1 Competitive Scenario of Global ART: By End User
6.2 Hospitals & Others - Market Size and Forecast (2015-2025)
6.3 Fertility Clinics - Market Size and Forecast (2015-2025)
7. Global ART Market Segmentation - By Product Type
7.1 Competitive Scenario of Global ART: By Product Type
7.2 Drugs - Market Size and Forecast (2015-2025)
7.3 Instruments - Market Size and Forecast (2015-2025)
7.4 Consumables - Market Size and Forecast (2015-2025)
7.5 Software & Services - Market Size and Forecast (2015-2025)
8. Global Assisted Reproductive Technology Market: Regional Analysis
8.1 Competitive Scenario of Global ART: By Region
9. Americas ART Market: Segmentation By Technology, End User, Product Type (2015-2025)
9.1 Americas ART Market: Size and Forecast (2015-2025), By Value
9.2 Americas ART Market - Prominent Companies
9.3 Market Segmentation By Technology (IVF, AI and Others)
9.4 Market Segmentation By End User (Hospitals & Others, Fertility Clinics)
9.5 Market Segmentation By Product Type (Consumables, Instruments, Drugs, Software & Services)
9.6 Americas ART Market: Country Analysis
9.7 Market Opportunity Chart of Americas ART Market - By Country, By Value, 2025
9.8 Competitive Scenario of Americas ART: By Country, Year 2019 & 2025
9.9 United States ART Market: Size and Forecast (2015-2025), By Value
9.10 United States ART Market Segmentation - By Technology, By End User, By Product Type
9.11 Canada ART Market: Size and Forecast (2015-2025), By Value
9.12 Canada ART Market Segmentation - By Technology, By End User, By Product Type
9.13 Mexico ART Market: Size and Forecast (2015-2025), By Value
9.14 Mexico ART Market Segmentation - By Technology, By End User, By Product Type
9.15 Brazil ART Market: Size and Forecast (2015-2025), By Value
9.16 Brazil ART Market Segmentation - By Technology, By End User, By Product Type
10. Europe ART Market: Segmentation By Technology, End User, Product Type (2015-2025)
10.1 Europe ART Market: Size and Forecast (2015-2025), By Value
10.2 Europe ART Market - Prominent Companies
10.3 Market Segmentation By Technology (IVF, AI and Others)
10.4 Market Segmentation By End User (Hospitals & Others, Fertility Clinics)
10.5 Market Segmentation By Product Type (Consumables, Instruments, Drugs, Software & Services)
10.6 Europe ART Market: Country Analysis
10.7 Market Opportunity Chart of Europe ART Market - By Country, By Value, 2025
10.8 Competitive Scenario of Europe ART: By Country, Year 2019 & 2025
10.9 Germany ART Market: Size and Forecast (2015-2025), By Value
10.10 Germany ART Market Segmentation - By Technology, By End User, By Product Type
10.11 United Kingdom ART Market: Size and Forecast (2015-2025), By Value
10.12 United Kingdom ART Market Segmentation - By Technology, By End User, By Product Type
10.13 Italy ART Market: Size and Forecast (2015-2025), By Value
10.14 Italy ART Market Segmentation - By Technology, By End User, By Product Type
11. Asia Pacific ART Market: Segmentation By Technology, End User, Product Type (2015-2025)
11.1 Asia Pacific ART Market: Size and Forecast (2015-2025), By Value
11.2 Asia Pacific ART Market - Prominent Companies
11.3 Market Segmentation By Technology (IVF, AI and Others)
11.4 Market Segmentation By End User (Hospitals & Others, Fertility Clinics)
11.5 Market Segmentation By Product Type (Consumables, Instruments, Drugs, Software & Services)
11.6 Asia Pacific ART Market: Country Analysis
11.7 Market Opportunity Chart of Asia Pacific ART Market - By Country, By Value, 2025
11.8 Competitive Scenario of Asia Pacific ART: By Country, Year 2019 & 2025
11.9 China ART Market: Size and Forecast (2015-2025), By Value
11.10 China ART Market Segmentation - By Technology, By End User, By Product Type
11.11 Japan ART Market: Size and Forecast (2015-2025), By Value
11.12 Japan ART Market Segmentation - By Technology, By End User, By Product Type
11.13 India ART Market: Size and Forecast (2015-2025), By Value
11.14 India ART Market Segmentation - By Technology, By End User, By Product Type
12. Global Assisted Reproductive Technology Market Dynamics
12.1 Drivers
12.2 Restraints
12.3 Trends
13. Market Attractiveness
13.1 Market Attractiveness Chart of Global ART Market - By Technology Segment, 2025
13.2 Market Attractiveness Chart of Global ART Market - By End User Segment, 2025
13.3 Market Attractiveness Chart of Global ART Market - By Product Type Segment, 2025
13.4 Market Attractiveness Chart of Global ART Market - By Region Segment, 2025
14. Key Developments in Assisted Reproductive Technology Market
15. Assisted Reproductive Technology Pipeline
16. Competitive Landscape and Market Share Analysis
16.1 Market Share of Leading Global Companies
16.2 Competitive Position of companies dealing in ART
17. Company Analysis
17.1 Irvine Scientific
17.2 Merck
17.3 Hamilton Thorne
17.4 Vitrolife
17.5 Monash IVF Group
17.6 INVO Bioscience
17.7 Cooper Surgical
17.8 Esco
17.9 Anecova
17.10 Nidacon International AB
List of Figures
Figure 1: Global ART Market Size, By Value, 2015-2025 (USD Million)
Figure 2: Global Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 3: Global Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 4: Global Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 5: Overweight Population aged 15+ in G7 countries, 2017 (%)
Figure 6: Global Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 7: Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 8: Global ART Market, By Technology, year 2019 & 2025
Figure 9: Global Assisted Reproductive Technology Market - By IVF , By Value (USD Million), 2015-2025
Figure 10: Global Assisted Reproductive Technology Market - By AI , By Value (USD Million), 2015-2025
Figure 11: Global Assisted Reproductive Technology Market - By Others, By Value (USD Million), 2015-2025
Figure 12: Global ART Market, By End User, Year 2019 & 2025
Figure 13: Global Assisted Reproductive Technology Market - By Hospitals & Others, By Value (USD Million), 2015-2025
Figure 14: Global Assisted Reproductive Technology Market - By Fertility Clinics, By Value (USD Million), 2015-2025
Figure 15: Global ART Market, By Product Type, Year 2019 & 2025
Figure 16: Global Assisted Reproductive Technology Market - By Drugs, By Value (USD Million), 2015-2025
Figure 17: Global Assisted Reproductive Technology Market - By Instruments, By Value (USD Million), 2015-2025
Figure 18: Global Assisted Reproductive Technology Market - By Consumables, By Value (USD Million), 2015-2025
Figure 19: Global Assisted Reproductive Technology Market - By Software and Services, By Value (USD Million), 2015-2025
Figure 20: Regional ART Market, Year 2019 & 2025
Figure 21: Americas Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 22: Americas Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 23: Americas Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 24: Americas Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 25: Americas Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 26: Latin America and Caribbean Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 27: North America and Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 28: Americas Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 29: Americas Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 30: Americas Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 31: Market Opportunity Chart of Americas Assisted Reproductive Technology Market - By Country, By Value (Year-2025)
Figure 32: Americas ART, By Country, Year 2019 & 2025
Figure 33: United States Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 34: United States Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 35: United States Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 36: United States Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 37: United States Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 38: United States Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 39: United States Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 40: United States Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 41: United States Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 42: Canada Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 43: Canada Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 44: Canada Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 45: Canada Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 46: Canada Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 47: Canada Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 48: Canada Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 49: Canada Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 50: Canada Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 51: Mexico Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 52: Mexico Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 53: Mexico Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 54: Mexico Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 55: Mexico Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 56: Mexico Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 57: Mexico Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 58: Mexico Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 59: Mexico Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 60: Brazil Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 61: Brazil Male Infertility Prevalence Rate, 2014 - 2017 (per 100k
Figure 62: Brazil Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 63: Brazil Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 64: Brazil Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 65: Brazil Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 66: Brazil Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 67: Brazil Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 68: Brazil Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 69: Europe Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 70: Europe Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 71: Europe Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 72: Europe Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 73: European Union Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 74: Europe Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 75: Europe total fertility rate(children/woman),2017
Figure 76: Europe Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 77: Europe Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 78: Europe Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 79: Market Opportunity Chart of Europe Assisted Reproductive technology Market - By Country, By Value, 2025
Figure 80: Europe ART, By Country, Year 2019 & 2025
Figure 81: Germany Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 82: Germany Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 83: Germany Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 84: Germany Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 85: Germany Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 86: Germany Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 87: Germany Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 88: Germany Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 89: Germany Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 90: United Kingdom Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 91: UK Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 92: UK Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 93: UK Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 94: UK Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 95: United Kingdom Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 96: UK Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 97: UK Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 98: UK Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 99: Italy Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 100: Italy Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 101: Italy Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 102: Italy Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 103: Italy Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 104: Italy Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 105: Italy Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 106: Italy Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 107: Italy Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 108: Asia Pacific Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 109: Asia Pacific Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 110: Asia Pacific Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 111: Asia Pacific Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 112: Asia Pacific Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 113: Asia Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 114: Asia Pacific Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 115: Asia Pacific Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 116: Asia Pacific Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 117: Market Opportunity Chart of Asia Pacific ART Market - By Country, By Value, 2025
Figure 118: Asia Pacific ART, By Country, Year 2019 & 2025
Figure 119: China Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 120: China Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 121: China Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 122: China Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 123: China Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 124: China Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 125: China Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 126: China Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 127: China Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 128: Japan Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 129: Japan Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 130: Japan Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 131: Japan Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 132: Japan Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 133: Japan Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 134: Japan Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 135: Japan Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 136: Japan Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 137: India Assisted Reproductive Technology Market Size, By Value, 2015-2025 (USD Million)
Figure 138: India Male Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 139: India Female Infertility Prevalence Rate, 2014 - 2017 (per 100k)
Figure 140: India Prevalence of Smoking among Persons Aged 15 and Above, 2013-2016 (In %)
Figure 141: India Total Fertility Rate, 2014 - 2017 (Births/Woman)
Figure 142: India Probabilistic Projections of Total Fertility using fertility estimates, 2019 (Median, 80%/95% Prediction Intervals)
Figure 143: India Assisted Reproductive Technology Market - By Technology, By Value, 2015-2025 (USD Million)
Figure 144: India Assisted Reproductive Technology Market - By End User, By Value, 2015-2025 (USD Million)
Figure 145: India Assisted Reproductive Technology Market - By Product Type, By Value, 2015-2025 (USD Million)
Figure 146: Market Attractiveness Chart of Global ART Market - By Technology Segment, 2025
Figure 147: Market Attractiveness Chart of Global ART Market - By End User, 2025
Figure 148: Market Attractiveness Chart of Global ART Market - By Product Type, By Value, 2025
Figure 149: Market Attractiveness Chart of Global ART Market - By Region, By Value, 2025
Figure 150: Market Share of Leading Global Assisted Reproductive Technology Companies, 2018 (In %)
Figure 151: Competitive Positions of companies dealing in Assisted Reproductive Technology (2018)
Figure 152: Merck Revenue, 2014-2018 (In USD Million)
Figure 153: Merck Revenue, By Region, 2017 (In %)
Figure 154: Merck Revenue, By Region, 2018 (In %)
Figure 155: Merck Revenue, By Business Segment, 2017 (In %)
Figure 156: Merck Revenue, By Business Segment, 2018 (In %)
Figure 157: Hamilton Thorne Sales Revenue, 2014 - 2018 (In USD Million)
Figure 158: Hamilton Thorne Net Income, 2014 - 2018 (In USD Million)
Figure 159: Hamilton Thorne Segment Sales Revenue, 2017 (In %)
Figure 160: Hamilton Thorne Segment Sales Revenue, 2018 (In %)
Figure 161: Vitrolife Net Sales, 2014 - 2018 (In USD Million)
Figure 162: Vitrolife Net Income, 2014-2018(In USD Million)
Figure 163: Vitrolife Net Sales, By Region, 2018 (In %)
Figure 164: Vitrolife Net Sales, By Business Sector, 2018 (In %)
Figure 165: Vitrolife Net Sales By Products and Services, 2018 (In %)
Figure 166: Monash IVF Group Revenue, 2015 - 2019 (In USD Million)
Figure 167: Monash IVF Group Revenue, By Region, 2018 (In %)
Figure 168: Monash IVF Group Revenue, By Region, 2019 (In %)
Figure 169: INVO Bioscience Revenue, 2014 - 2018 (In USD Thousands)
Figure 170: INVO Bioscience, Net Loss, 2014-2018(In Thousands)
Figure 171: Cooper Companies Inc. & Subsidiaries, Net Sales 2015-2019 (In USD Million)
Figure 172: Cooper Surgical Net Sales 2015-2019(In USD Million)
Figure 173: Cooper Surgical Net Sales By Category, 2019, (%)
Figure 174: Cooper Surgical Net Sales By Category, 2018, (%)
List of Tables
Table A: Fertility Drugs Used during Assisted Reproductive Treatment
Table B: Global Market Share Analysis of Companies
Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 119
According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period.
The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......
Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 132
According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period.
The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......
Global Contraceptives Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 141
According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period.
The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......
Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 108
According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period.
The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......
Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 28-Dec-2023 Price: US 3380 Onwards Pages: 99
Market Overview of Global Menopausal Hot Flashes market:
According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......
Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)
Published: 15-Dec-2023 Price: US 3200 Onwards Pages: 139
Report Overview:
This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs.
The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......
Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)
Published: 15-Dec-2023 Price: US 3200 Onwards Pages: 122
Report Overview:
The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......
Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 05-Dec-2023 Price: US 3380 Onwards Pages: 108
Market Overview of Global Bacterial Vaginosis Drug market:
According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years.
Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......
Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 30-Nov-2023 Price: US 3380 Onwards Pages: 123
Market Overview of Global Tocolysis Drugs market:
According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
